Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ · Healthcare
Black Diamond Therapeutics, Inc. Cash on Hand 2018–2025
Black Diamond Therapeutics, Inc. annual/quarterly cash on hand history from 2018 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Black Diamond Therapeutics, Inc. cash on hand for the quarter ending December 31, 2025 were 21.0M, a 42.39% decrease year-over-year.
- Black Diamond Therapeutics, Inc. cash on hand for 2025 were 21.0M, a 42.39% decrease from 2024.
- Black Diamond Therapeutics, Inc. cash on hand for 2024 were 36.4M, a 5.29% increase from 2020.
- Black Diamond Therapeutics, Inc. cash on hand for 2020 were 34.6M, a 77.63% decrease from 2019.
- Black Diamond Therapeutics, Inc. cash on hand for 2019 were 154.7M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Black Diamond Therapeutics, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $21 |
| 2024 | $36 |
| 2020 | $35 |
| 2019 | $155 |
| 2018 | $52 |
| Black Diamond Therapeutics, Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $21 |
| 2024-12-31 | $36 |
| 2020-12-31 | $35 |
| 2019-12-31 | $155 |
| 2018-12-31 | $52 |
Black Diamond Therapeutics, Inc. Cash on Hand — FAQ
Black Diamond Therapeutics, Inc. (BDTX) cash on hand over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BDTX's cash on hand history?
The chart and table above show Black Diamond Therapeutics, Inc.'s cash on hand by year and by quarter, including the growth rate.